Kong Y - Search Results

1

Gao M, Kong Y, Yang G, Gao L, Shi J. Gao M, et al. Among authors: kong y. Oncotarget. 2016 Jun 7;7(23):35466-77. doi: 10.18632/oncotarget.8154. Oncotarget. 2016. PMID: 27007154 Free PMC article. Review.

2

Synergistic Activity of Carfilzomib and Panobinostat in Multiple Myeloma Cells via Modulation of ROS Generation and ERK1/2.

Gao L, Gao M, Yang G, Tao Y, Kong Y, Yang R, Meng X, Ai G, Wei R, Wu H, Wu X, Shi J. Gao L, et al. Among authors: kong y. Biomed Res Int. 2015;2015:459052. doi: 10.1155/2015/459052. Epub 2015 Apr 27. Biomed Res Int. 2015. PMID: 26000292 Free PMC article.

3

Smoldering multiple myeloma.

Gao M, Yang G, Kong Y, Wu X, Shi J. Gao M, et al. Among authors: kong y. Biomed Res Int. 2015;2015:623254. doi: 10.1155/2015/623254. Epub 2015 Apr 27. Biomed Res Int. 2015. PMID: 26000300 Free PMC article. Review.

4

Carfilzomib enhances natural killer cell-mediated lysis of myeloma linked with decreasing expression of HLA class I.

Yang G, Gao M, Zhang Y, Kong Y, Gao L, Tao Y, Han Y, Wu H, Meng X, Xu H, Zhan F, Wu X, Shi J. Yang G, et al. Among authors: kong y. Oncotarget. 2015 Sep 29;6(29):26982-94. doi: 10.18632/oncotarget.4831. Oncotarget. 2015. PMID: 26323098 Free PMC article.

5

Thalidomide treatment for patients with previously untreated multiple myeloma: a meta-analysis of randomized controlled trials.

Gao M, Kong Y, Wang H, Xie B, Yang G, Gao L, Zhang Y, Zhan F, Dai B, Tao Y, Shi J. Gao M, et al. Among authors: kong y. Tumour Biol. 2016 Aug;37(8):11081-98. doi: 10.1007/s13277-016-4963-8. Epub 2016 Feb 23. Tumour Biol. 2016. PMID: 26906553

6

Overexpression of RPS27a contributes to enhanced chemoresistance of CML cells to imatinib by the transactivated STAT3.

Wang H, Xie B, Kong Y, Tao Y, Yang G, Gao M, Xu H, Zhan F, Shi J, Zhang Y, Wu X. Wang H, et al. Among authors: kong y. Oncotarget. 2016 Apr 5;7(14):18638-50. doi: 10.18632/oncotarget.7888. Oncotarget. 2016. PMID: 26942564 Free PMC article.

7

Therapeutic potential and functional interaction of carfilzomib and vorinostat in T-cell leukemia/lymphoma.

Gao M, Chen G, Wang H, Xie B, Hu L, Kong Y, Yang G, Tao Y, Han Y, Wu X, Zhang Y, Dai B, Shi J. Gao M, et al. Among authors: kong y. Oncotarget. 2016 May 17;7(20):29102-15. doi: 10.18632/oncotarget.8667. Oncotarget. 2016. PMID: 27074555 Free PMC article.

8

Preclinical activity of DCZ3301, a novel aryl-guanidino compound in the therapy of multiple myeloma.

Gao M, Li B, Sun X, Zhou Y, Wang Y, Tompkins VS, Xu Z, Indima N, Wang H, Xiao W, Gao L, Chen G, Wu H, Wu X, Kong Y, Xie B, Zhang Y, Chang G, Hu L, Yang G, Dai B, Tao Y, Zhu W, Shi J. Gao M, et al. Among authors: kong y. Theranostics. 2017 Aug 23;7(15):3690-3699. doi: 10.7150/thno.18345. eCollection 2017. Theranostics. 2017. PMID: 29109769 Free PMC article.

9

Rafoxanide, an organohalogen drug, triggers apoptosis and cell cycle arrest in multiple myeloma by enhancing DNA damage responses and suppressing the p38 MAPK pathway.

Xiao W, Xu Z, Chang S, Li B, Yu D, Wu H, Xie Y, Wang Y, Xie B, Sun X, Kong Y, Lan X, Bu W, Chen G, Gao L, Wu X, Shi J, Zhu W. Xiao W, et al. Among authors: kong y. Cancer Lett. 2019 Mar 1;444:45-59. doi: 10.1016/j.canlet.2018.12.014. Epub 2018 Dec 21. Cancer Lett. 2019. PMID: 30583070

10

Ferroportin downregulation promotes cell proliferation by modulating the Nrf2-miR-17-5p axis in multiple myeloma.

Kong Y, Hu L, Lu K, Wang Y, Xie Y, Gao L, Yang G, Xie B, He W, Chen G, Wu H, Wu X, Zhan F, Shi J. Kong Y, et al. Cell Death Dis. 2019 Aug 19;10(9):624. doi: 10.1038/s41419-019-1854-0. Cell Death Dis. 2019. PMID: 31423010 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,589 results

Search Page